학술논문
Leukemic stem cells of acute myeloid leukemia patients carrying NPM1 mutation are candidates for targeted immunotherapy.
Document Type
Article
Author
Source
Subject
*ADULT T-cell leukemia
*NUCLEOPHOSMIN
*ACUTE myeloid leukemia
*PROGNOSIS
*
*
*
Language
ISSN
0887-6924
Abstract
A letter to the editor is presented which discusses the immune response of cytotoxic T-cell (CTL) against the mutated protein of nucleophosmin 1 (NPM1) which are favorable to the prognosis of acute myeloid leukemia (AML).